Ecasil 600mg/300ml IV Injection (Sami)  is a cephalosporin-class antibiotic used to treat moderate to severe bacterial infections. It contains Cefaclor, a second-generation cephalosporin, known for its broad-spectrum activity against various gram-positive and gram-negative bacteria. This intravenous (IV) formulation is specifically designed for hospitalized patients or individuals requiring parenteral antibiotic therapy for conditions such as: Ecasil 600mg/300ml IV Injection (Sami) 

• Respiratory tract infections (pneumonia, bronchitis, sinusitis)
• Skin and soft tissue infections
• Urinary tract infections (UTIs)
• Severe throat infections (tonsillitis, pharyngitis)
• Bone and joint infections

Administered via IV infusion Ecasil 600mg/300ml IV Injection (Sami)  ensures rapid bloodstream absorption, allowing for quick bacterial eradication and enhanced treatment outcomes. It is often recommended when oral antibiotics are not effective or feasible.

Key Benefits:
✔ Broad-spectrum antibiotic for serious bacterial infections
✔ IV infusion ensures rapid and effective drug delivery
✔ Effective against respiratory, skin, urinary, and systemic infections
✔ Doctor-prescribed and pharmacist-approved
✔ Suitable for hospitalized patients requiring intensive therapy

Important Note: Ecasil 600mg/300ml IV Injection (Sami) 

• To be administered only under medical supervision.
• Dosage and duration must be followed as prescribed by a healthcare professional.
• Not for self-administration – to be given by a qualified medical professional in a clinical setting.